Acarix AB (publ) (ACARIX.ST)

0.2370 -0.0060 (-2.47%) As of 02:10PM CEST. Market open.

Acarix AB (publ)

Jungmansgatan 12
Malmö 211 19
Sweden

https://www.acarix.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Aamir Mahmood	Chief Executive Officer	N/A	N/A	N/A
Dr. Claus Bo Vöge Christensen	Founder and Interim Head of R&D	N/A	N/A	1964
Mr. Christian Lindholm	CFO & Executive VP	2.28M	N/A	1964
Mr. Thomas Stig Lundstroem	Chief Operations Officer	N/A	N/A	1974
Ms. Jennifer Anderson	Head of Marketing & Communication	N/A	N/A	1979
Ms. Jennifer Matson	Head of Medical Affairs	N/A	N/A	1977

Amounts are as of 31 December 2018, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out in Sweden and internationally. It offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced AI to analyze the patient's coronary blood flow. The company was founded in 2009 and is headquartered in Malmö, Sweden.

Corporate governance

Acarix AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.